Chronic Pain Clinical Trial
Official title:
PainTracker Self-Manager: Development and Testing of a Web-based Platform to Promote and Track Chronic Pain Self-management and Other Treatment Outcomes
To develop and test a web-based patient empowerment platform, PainTracker Self-Manager (PTSM), that can support integrated multimodal care in a variety of specialty and primary care settings. The investigators will adapt PainTracker, a web-based outcome and treatment tracking tool already deployed in multiple University of Washington clinics to create the PTSM self-management tool that helps assess, engage, activate, and support patients' efforts to self-manage their chronic pain in collaboration with their clinicians. PTSM design will be based on 4-phase patient engagement strategy derived from Acceptance and Commitment Therapy. Phase 1 focuses on achieving consensus on the clinical problem definition, treatment goals and timeline. Phase 2 focuses on promoting values-based action and acceptance of pain. Phase 3 focuses on providing skills in chronic pain self-management with close monitoring of patient reported outcomes and actigraphy. Phase 4 focuses on providing autonomy support to promote maintenance of self-management behaviors. Phase 5 involves generating a patient registry with the above data for use in quality improvement research. The investigators will engage patients, providers and investigators in designing PTSM, reviewing prototypes, and conducting usability testing. In a 6-month clinical trial, the investigators will compare 50 intervention patients from the UW Center for Pain Relief who receive PTSM to 50 historical control patients who have received the basic PainTracker. The primary outcome will be chronic pain self-efficacy, with secondary outcomes of: chronic pain acceptance, perceived efficacy in physician-patient interactions, and patient and provider satisfaction. Development of the PTSM platform will support the dissemination of the multimodal interdisciplinary care for chronic pain that is recommended in the National Pain Strategy, and may help chronic pain care meet the goals of the Triple Aim: better patient experience, better patient outcomes, with lower costs.
Patients and Setting Study participants (N = 99) were patients seeking care for various
chronic pain conditions at the UW CPR between April 2016 and March 2017. The target
population for the study was patients who had received an initial treatment planning visit,
but who were still early in their course of treatment. Therefore, to be eligible for this
study, patients were required to have visited the UW CPR at least once, but not more than 5
times. The control subjects were recruited between April 2016 and September 2016 while the
intervention was being developed.The intervention subjects were recruited between September
2016 and March 2017. This sequential, nonrandomized design was chosen because of the limited
budget and time available for the development and testing of our intervention.
Measures Demographic and clinical data were extracted from UW CPR electronic medical records.
Demographic data collected at enrollment included age, sex, race, ethnicity, and insurance
type. Clinical data collected on control and intervention subjects included pain diagnoses,
previous and current interventional treatments and therapies for pain,as well as current pain
and related medications (opioids, anticonvulsants, antidepressants, anxiolytics,
antihistamines, and nonsteroidal anti-inflammatory drugs.
The Pain Self-Efficacy Questionnaire24,25 is a 10-item survey that assesses patients' pain
self-efficacy, or confidence in their ability to cope with their pain and continue activities
of daily living (eg, "I can cope with my pain in most situations."). Items are scored on a
7-point scale from 0 "not at all confident" to 10 "completely confident." Higher scores
denote higher pain self-efficacy. The questionnaire is widely used across various chronic
pain conditions and has strong psychometric properties.25 Scores range from 0 to 60. This was
prespecified as our primary outcome measure. The Chronic Pain Acceptance Questionnaire40 was
used to evaluate chronic pain acceptance. This 20-item survey is composed of 2 factors: 1)
"activity engagement": engagement in life activities with pain (11 items), and 2) "pain
willingness": willingness to experience pain without trying to engage in unhelpful attempts
to control it (9 items). Patients were asked to rate the truth of each item as it applied to
them (eg, "My life is going well, even though I have chronic pain."). Items are scored on
7-point scale from 0 "never true" to 6 "always true." Higher scores denote greater levels of
pain acceptance. Scores on the "activity engagement" subscale range from 0 to 66; scores on
the "pain willingness" subscale range from 0 to 54). The Chronic Pain Acceptance
Questionnaire has good psychometric properties28 as well as evidence of clinical utility.40
The Perceived Efficacy in Patient-Physician Interactions21 is a 5-item survey measuring
confidence in obtaining medical information and attention to their medical concerns from
physicians. Items are scored on a 5-point Likert scale from 1 "not at all confident" to 5
"very confident." The Perceived Efficacy in Patient-Physician Interactions has established
validity and reliability in older adults21 and patients with osteoarthritis.35 Pain and pain
interference were evaluated using the 3-item Pain Intensity and Interference With Enjoyment
of Life and General Activity (PEG).16 Pain intensity was rated on an 11-point numeric rating
scale, from 0 "nopain" to 10 "pain as bad as you can imagine." For interference items,
patients indicated how much pain interfered with enjoyment of life and with general activity
from 0 "does not interfere" to 10 "completely interferes." The PEG total score is the mean of
these 3 items, where higher values denote a higher level of pain intensity and interference.
The PEG has established reliability and validity in a community and veteran populations with
chronic pain and has shown responsiveness to improvement similar to the Brief Pain
Inventory.15 The PEG was completed as part of the participant's regular clinical care.
Assessments within 2 months of the primary PTSM outcome assessment were used for these
analyses. To evaluate satisfaction with pain treatment, participants were asked to choose the
number between 0 "extremely dissatisfied" and 10 "extremely satisfied" that best reflected
how satisfied they are with the results of their pain treatment, in general.
Study Procedures Consecutive new patients who attended the UW CPR between April 2016 and
March 2017 completed a collection of pain-relevant patient-reported outcome questionnaires
using PainTracker to facilitate comprehensive multidimensional pain care. All new patients
were asked to complete the online questionnaires 1 week before their scheduled appointment.
Those who were scheduled for a follow-up appointment at UW CPR and completed the follow-up
PainTracker assessment were presented with a question determining interest in the PTSM study.
If patients were interested in learning about the study, they were directed to an online
information statement outlining the purposes and procedures of the study and given the
opportunity to enroll. Patients who chose to not consent at the time were given the options
to decide at a later time or obtain more information regarding the study. These patients were
then sent a followup e-mail by the research team. Intervention and control subjects were
compensated with a $100 gift card for completion of all outcome measures.
A controlled, sequential, nonrandomized study design was used. During the first 6 months of
the enrollment period, assessment procedures for the control group were conducted. The
control group received treatment as usual in the CPR, with no restrictions on treatment
received, including medications, procedures, and sessions with pain psychology, pain
psychiatry, and social work that provided support for pain self-management. While control
subjects were being assessed, the Web-based PTSM platform for the intervention phase of the
study was developed by the multidisciplinary research team, which included investigators from
psychiatry, internal medicine, psychology, nursing, social work, computer science, and
graphic design. During the second 6 months of the study enrollment period, patients were
enrolled in the intervention group. Control as well as intervention subjects were followed
for 6 months. There was no restriction on treatments received in either group. The study
procedures were reviewed and approved by the institutional review board at UW. Intervention
The intervention included exposure, at the patient's discretion, to a Web-based patient
empowerment platform on the basis of Acceptance and Commitment Therapy (ACT) principles, as
well as phone and text coaching from the research clinicians (P.S.D. and C.T., trained in
nursing and social work, respectively). The flow of the study is shown in Fig 1. The PTSM
interactive educational modules covered the following topics: module A: "Introduction to
PainTracker" is a brief, noninteractive informational module that was presented to the
intervention as well as control patients as an introduction to the first PainTracker
assessment. Module B: "What is Pain?," explained that pain is important, unpredictable, and
complex. It emphasized that all pain is real and important. It also emphasized that pain may
get better and worse for unclear reasons. It did not focus on the difference between acute
and chronic pain. Education on the complexity of pain used concepts of "injury" versus
"alarm," and incorporated some ideas from Explain Pain by Butler and Moseley.5,23 Module C:
"Life Navigation System," assisted patients with clarifying values and developing an action
plan to improve 1 selected life area (ie, free time, relationships, health and self-care, or
work and education). This module was adapted from a treatment manual written by Vowles and
Sorrell38 and incorporated the Values Bullseye exercise of Lundgren and colleagues.19 Module
D: "Get Rhythm," focused on pacing, mindful breathing, and sleep rhythms. These 3 areas were
selected for skill development because they are often core components of behavioral
treatments for chronic pain and because of their relevance with the values focus of the
intervention. Participants were encouraged to bring some regular rhythm into their lives,
particularly as related to engagement in valued living. Module E: "Life Goes On," the final
module, focused on scheduling value-based activities and managing pain flares over the longer
term. These themes were chosen to emphasize the importance of engagement in value-based
activities for sustained recovery.2 Intervention participants were given access to all
modules at the outset of the study. They were not forced to complete them on a schedule or in
order. The coaches strived to have at least 1 coaching session after the completion of each
module.The coaches estimate that patients spent 30 to 40 minutes on each module that they
viewed. Module A was especially short and Module B was especially long. Total estimated time
for module viewing was 120 to 160 minutes. More precise tracking of viewing time was not
possible because of patients' ability to leave the modules open while they attend to other
things. Embedded in each of the interactive modules were open-ended and multiple choice
questions and tasks, such as "Of all the things that have happened to you since your pain
started, what concerns you the most?" or "Create your own action plan." The responses to
these module questions were visible to the coaches and were used to guide and tailor the
coaching sessions to the individual patient. Coaching sessions occurred in person (14%), over
the phone (85%), or by e-mail and text (1%), on an average of 4 occasions (SD = 1.6)
depending on participant preference and availability, with a mean duration of 20 minutes (SD
= 8.6, range = 2-50 minutes per session). After each individual coaching session,
participants were sent an e-mail summary of the recommendations discussed. At study
completion, a final note was sent with a summary of key self-management strategies, and
encouragement to continue to incorporate them into daily life. The patient coach's general
approach within each coaching session was to use open, active listening strategies to
establish therapeutic rapport. Coaching sessions were focused on incorporating and engaging
participants in the PTSM study educational content. Module content was reviewed and questions
or concerns were addressed. Participants were asked to identify 1 to 2 simple and achievable
goals on the basis of suggestions in the module, and were guided to identify specific
strategies to meet the goal. Efforts were made to redirect conversations from excessive
review of pain complaints to values, functioning, goal-setting, and self-care. Questions
regarding specific diagnoses or medical therapies were directed to the UW CPR provider. Each
week, the team met to discuss 1 or 2 challenging cases, and to provide the research
clinicians with supervision. Suggestions for strategies to promote engagement in the study
educational content were provided by pain psychiatry and psychology (M.S., K.E.V., R.V.).
Brief summaries of the coaching session and customized suggestions for engagement of the
patient in pain self-management were provided to the patient's UW CPR provider at their next
clinic visit on a printed sheet placed on top of the patient's clinical chart.
Data Analysis Data were analyzed using SPSS version 25 (IBM Corp, Armonk, NY). Descriptive
statistics and frequency distributions were calculated for sample characteristics.
Independent samples t-tests for continuous variables and χ2 tests for categorical variables
were used to evaluate for differences in demographic and clinical characteristics between the
control and intervention groups. Adjustments were not made for missing data. A P value of
<.05 was considered statistically significant. Generalized estimating equations (GEE) were
used to evaluate the effect of the intervention on primary (pain self-efficacy) and secondary
(chronic pain acceptance, perceived efficacy in patient-provider interactions, pain intensity
and interference, satisfaction with pain treatment) outcomes. GEE is an extension of
generalized linear models that allows for the analysis of repeated measures with unknown
covariance structure. GEE uses any and all available data that participants provide, even if
follow-up data are missing (ie, intent-to-treat analysis). For all models, the main effect of
group and time, and the Group × Time interaction were evaluated. For this pilot study,Wald χ2
statistics with P values <.05 for overall model effects were considered statistically
significant. For models with significant Group × Time interactions, the main effects of group
or time were not reported. For models with only a significant main effect of time, models
were rerun without the interaction term to obtain the true main effect. GEE models for the
entire study sample and for only those who provided outcome data at all study time points
(baseline, 3 months, 6 months) were evaluated.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|